Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
69.87 USD | -2.32% | -2.84% | -6.60% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Hologic, Inc. is the world leader in the design, manufacturing and marketing of diagnostic products, medical imaging systems and surgical products dedicated to women's health. Net sales break down by area of application as follows:
- molecular diagnostics (62.1%): rapid diagnostic tests for human diseases detection (sexually transmitted infections, respiratory diseases, viral diseases, infectious diseases, cancers of the cervix and prostate, etc.) and fetal fibronectin;
- breast health (25.3%): digital mammography and breast biopsy solutions and systems;
- gynecological surgery (10.8%): endometrial ablation devices, minimally invasive intervention systems for the hysteroscopic elimination of targeted intrauterine diseases (including fibroids and polyps). The group also offers fluid management systems for use in hysteroscopic procedures;
- bone health (1.97%): bone imaging systems, bone sonometers and osteodensitometers for bone structure and density, and osteoporotic fractures risk assessment.
Net sales break down by source of revenue between sales of products (86.2%) and services (13.8%).
Net sales are distributed geographically as follows: the United States (71.3%), Europe (18.3%), Asia/Pacific (7.4%) and other (3%).
Calendar
2024-01-30
- Q1 2024 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
B+
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
69.87USD
Average target price
79.83USD
Spread / Average Target
+14.25%
EPS Revisions
1st Jan change | Capi. (M$) | |
---|---|---|
-6.60% | 16 769 M $ | |
-11.76% | 188 B $ | |
-17.58% | 162 B $ | |
+17.18% | 109 B $ | |
+18.72% | 80 472 M $ | |
+9.91% | 62 968 M $ | |
-9.93% | 48 160 M $ | |
-16.67% | 36 431 M $ | |
+16.70% | 31 016 M $ | |
-25.20% | 22 900 M $ |
- Stock
- Equities
- Stock Hologic, Inc. - Nasdaq
- News Hologic, Inc.
- Hologic Says US Appeals Court Affirms 2018 Patent Infringement Ruling